 Times LIVE | India rejects Bayer plea against cheap cancer drug Times LIVE ... India's patent office allowed local drug manufacturer Natco Pharma Ltd. to produce a generic version of Bayer's kidney and liver cancer treatment Nexavar on the grounds that this would make the drug available to the public at a reasonably ... Bayer loses plea against cheap Indian cancer drug Bayer fails to overturn Nexavar compulsory licence in India Bayer loses appeal in Indian compulsory licence case |
